Vanguard Personalized Indexing Management LLC Has $12.05 Million Stock Position in Cencora, Inc. $COR

Vanguard Personalized Indexing Management LLC grew its holdings in shares of Cencora, Inc. (NYSE:COR) by 5.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,661 shares of the company’s stock after buying an additional 1,778 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Cencora were worth $12,045,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Oakworth Capital Inc. acquired a new position in shares of Cencora during the fourth quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora during the fourth quarter valued at about $27,000. Archer Investment Corp grew its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. Motiv8 Investments LLC acquired a new position in shares of Cencora during the fourth quarter valued at about $29,000. Finally, Optima Capital LLC acquired a new position in shares of Cencora during the fourth quarter valued at about $31,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COR has been the subject of a number of analyst reports. Barclays reduced their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Morgan Stanley set a $342.00 price objective on shares of Cencora in a report on Friday, May 8th. Robert W. Baird reduced their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. UBS Group boosted their price target on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, Wells Fargo & Company cut their price target on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Cencora presently has a consensus rating of “Moderate Buy” and an average target price of $374.00.

Cencora Stock Down 0.0%

Cencora stock opened at $281.58 on Tuesday. The stock has a market cap of $54.78 billion, a PE ratio of 21.59, a price-to-earnings-growth ratio of 1.52 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm’s 50-day simple moving average is $288.36 and its 200 day simple moving average is $326.67.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the firm posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has approved a stock repurchase program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.